• $826,639.00
    Market Cap
  • -89.57%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
07/31/2026
07/31/2025
07/31/2024
07/31/2023
Income Statement
Total Operating Revenue
0
+100.00%
-459,417
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
+100.00%
-459,417
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
0
N/A
0
N/A
0
+100.00%
-201,329
-115.29%
Depreciation and Amortization Expense
N/A
N/A
0
-100.00%
1,538
-54.98%
3,416
+43.89%
Total Operating Expenses
912,994
-10.56%
1.0M
-32.25%
1.5M
-29.01%
2.1M
-68.74%
Operating Profit
-912,994
-10.56%
-1.0M
-107.16%
14.3M
+368.37%
-5.3M
-34.45%
Interest Income
0
+100.00%
-459,417
N/A
N/A
N/A
8,677
N/A
Interest Expense
-34,007
0.00%
-34,007
0.00%
-34,007
-94.46%
-614,083
-26.57%
Interest Income and Expense and Net
-34,007
-93.11%
-493,424
+1,350.95%
-34,007
-94.38%
-605,406
-172.39%
Total Nonoperating Income and Expense
-10,176
+1.71%
-10,005
-207.99%
9,265
+6.78%
8,677
-98.96%
Income before Taxes
-912,994
-47.61%
-1.7M
+92.40%
-905,771
-82.96%
-5.3M
-34.45%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
0
-100.00%
13.0M
N/A
N/A
N/A
Net Income
N/A
N/A
-1.7M
+106.89%
-842,316
-85.77%
-5.9M
-29.90%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-1.7M
+92.40%
-905,771
-84.70%
-5.9M
-29.90%
Basic EPS and Net Income
-0.05
+150.00%
-0.02
+100.00%
-0.01
-85.71%
-0.07
-22.22%
Diluted EPS and Net Income
-0.05
+150.00%
-0.02
+100.00%
-0.01
-85.71%
-0.07
-22.22%
Basic Weighted Average Shares
108.3M
+3.45%
104.7M
+7.88%
97.1M
+17.40%
82.7M
-7.10%
Diluted Weighted Average Shares
108.3M
+3.45%
104.7M
+7.88%
97.1M
+17.40%
82.7M
-7.10%
Balance Sheet
Cash and Cash Equivalents
122,361
+541.17%
19,084
+702.19%
2,379
-93.55%
36,865
-49.18%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
122,361
+541.17%
19,084
+702.19%
2,379
-93.55%
36,865
-49.18%
Total Current Assets
147,859
+197.37%
49,723
-12.68%
56,943
-85.97%
405,888
-22.90%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
147,859
+197.37%
49,723
-91.52%
586,146
+28.60%
455,793
-19.99%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
3.1M
+62.77%
1.9M
+21.83%
1.5M
-23.43%
2.0M
+31.84%
Total Current Liabilities
12.3M
+75.28%
7.0M
+18.32%
5.9M
-10.46%
6.6M
+26.82%
Total Long-Term Debt
6.9M
+318.69%
1.7M
-48.85%
3.2M
-7.44%
3.5M
N/A
Total Long-Term Liabilities
4.9M
+36,251.49%
13,343
-78.97%
63,455
-71.16%
220,000
N/A
Total Liabilities
12.3M
+75.28%
7.0M
+18.32%
5.9M
-10.46%
6.6M
+26.82%
Retained Earnings
-68.5M
+9.13%
-62.7M
+2.86%
-61.0M
+1.51%
-60.1M
+10.93%
Total Stockholders Equity
-12.1M
+74.41%
-7.0M
+30.39%
-5.3M
-13.36%
-6.2M
+32.57%
Total Shares Outstanding
106.0M
+9.57%
96.7M
0.00%
96.7M
+22.31%
79.1M
+1.55%
Cash Flow
Cash from Operating Activities
-1.0M
+201.20%
-347,392
-71.41%
-1.2M
-17.60%
-1.5M
-53.56%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
-100.00%
69,787
-93.02%
1.0M
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.1M
+290.62%
294,310
+62.85%
180,724
-87.53%
1.4M
-47.05%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
222.18%
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
-548.13%
+239.02%
-161.68%
-86.00%
-1,154.48%
-19.32%
Return on Equity
N/A
N/A
28.36%
+93.45%
14.66%
-86.63%
109.62%
-51.89%
Revenue Growth
100.00%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.01
+69.01%
0.007
-26.04%
0.010
-84.36%
0.06
-39.21%
Cash Ratio
0.01
+270.37%
0.003
+575.00%
0.0004
-92.86%
0.006
-59.71%
Debt-to-Equity Ratio
-0.83
+62.06%
-0.51
-43.28%
-0.90
+0.08%
-0.90
N/A
Debt-to-Assets Ratio
67.74
-4.96%
71.27
+771.96%
8.17
-32.57%
12.12
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow